Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

388 ARTÍCULOS , VIENDO DEL 1 AL 15

Natural Polyphenols in the Treatment of Alzheimer's Disease

Syarifah-Noratiqah SB, Naina-Mohamed I, Zulfarina MS, Qodriyah HMS.

Curr Drug Targets. 2018;19(8):927-937. doi: 10.2174/1389450118666170328122527.

Hydroxypyridinone Derivatives: A Fascinating Class of Chelators with Therapeutic Applications - An Update

Chaves S, Piemontese L, Hiremathad A, Santos MA.

Curr Med Chem. 2018;25(1):97-112. doi: 10.2174/0929867324666170330092304.

Tau in Alzheimer's Disease: Mechanisms and Therapeutic Strategies

Gao Y, Tan L, Yu JT, Tan L.

Curr Alzheimer Res. 2018;15(3):283-300. doi: 10.2174/1567205014666170417111859.

Targeting PPARalpha in Alzheimer's Disease

D'Orio B, Fracassi A, Ceru MP, Moreno S.

Curr Alzheimer Res. 2018 Feb 22;15(4):345-354. doi: 10.2174/1567205014666170505094549.

Multi-Target-Directed Ligands Affecting Serotonergic Neurotransmission for Alzheimer's Disease Therapy: Advances in Chemical and Biological Research

Jankowska A, Wesolowska A, Pawlowski M, Chlon-Rzepa G.

Curr Med Chem. 2018;25(17):2045-2067. doi: 10.2174/0929867324666170529122802.

The Blood Brain Barrier and its Role in Alzheimer's Therapy: An Overview

Jakki SL, Senthil V, Yasam VR, Chandrasekar MJN, Vijayaraghavan C.

Curr Drug Targets. 2018;19(2):155-169. doi: 10.2174/1389450118666170612100750.

Associations of acetylcholinesterase inhibitor treatment with reduced mortality in Alzheimer's disease: a retrospective survival analysis

Mueller C, Perera G, Hayes RD, Shetty H, Stewart R.

Age Ageing. 2018 Jan 1;47(1):88-94. doi: 10.1093/ageing/afx098.

Effects and mechanisms of actions of phytochemicals on Alzheimer's disease neuropathology

Hartman RE, Ross DM.

Front Biosci (Elite Ed). 2018 Jan 1;10(2):300-333. doi: 10.2741/e824.

CORAL: Monte Carlo Method to Predict Endpoints for Medical Chemistry

Toropova AP, Toropov AA.

Mini Rev Med Chem. 2018 Feb 14;18(5):382-391. doi: 10.2174/1389557517666170927154931.

Beyond The Therapeutic Effect of rTMS in Alzheimer's Disease: A Possible Neuroprotective Role of Hippocampal BDNF? : A Minireview

Yulug B, Hanoglu L, Khanmammadov E, Duz OA, Polat B, Hanoglu T, Gunal MY, Kilic E.

Mini Rev Med Chem. 2018;18(17):1479-1485. doi: 10.2174/1389557517666170927162537.

Nanotechnology in Personalized Medicine: A Promising Tool for Alzheimer's Disease Treatment

De Matteis L, Martín-Rapún R, de la Fuente JM.

Curr Med Chem. 2018;25(35):4602-4615. doi: 10.2174/0929867324666171012112026.

Downregulated apoptosis and autophagy after anti-Aβ immunotherapy in Alzheimer's disease

Paquet C, Nicoll JA, Love S, Mouton-Liger F, Holmes C, Hugon J, Boche D.

Brain Pathol. 2018 Sep;28(5):603-610. doi: 10.1111/bpa.12567. Epub 2018 Feb 6.

Combining in vitro and in silico Approaches to Find New Candidate Drugs Targeting the Pathological Proteins Related to the Alzheimer's Disease

Li H, Wang X, Yu H, Zhu J, Jin H, Wang A, Yang Z.

Curr Neuropharmacol. 2018;16(6):758-768. doi: 10.2174/1570159X15666171030142108.

Cognitive Training in Patients with Alzheimer's Disease: Findings of a 12-month Randomized Controlled Trial

Trebbastoni A, Imbriano L, Podda L, Rendace L, Sacchetti ML, Campanelli A, D'Antonio F, de Lena C.

Curr Alzheimer Res. 2018 Mar 14;15(5):452-461. doi: 10.2174/1567205014666171113105044.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias